A Brisbane clinic is set to begin human trials on a drug that’s exhibited a strong anti-viral effect against COVID-19.
Niclosamide has been used as an anti-parasitic treatment since it was developed in 1958 and sold worldwide under the name Yomesan.
The drug works by preventing a virus from invading host cells, and thereby suppresses its proliferation.